Guidelines Development Group
The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.
An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.
Members and external experts
Chris J.M. De Wolf
Former GDG clinical co-chair
Chris J.M. De Wolf (MD, MPH) is a medical expert in breast cancer screening in Switzerland and director of ADSAN (Agence pour le développement et évaluation des politiques de santé).
I studied medicine in the Netherlands and graduated in 1988. Immediate afterwards I was engaged by the policy development department of the Dutch Ministry of Health (STABO 1989 – 1990). On request of the European Commission, I worked on European cancer screening strategies (Europe against Cancer) for 8 years (Brussels, Luxembourg) were I was charged with the development of the European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. In 1999, I took a position as Head Screening and Early Detection at the International Union against Cancer (UICC, Geneva). Between 2004 - 2014 I was medical director for the breast cancer screening program in Fribourg and afterwards in Bern.
Currently I am quality assurance specialist for swiss cancer screening, medical director of the Programme valaisan de dépistage du cancer du sein, consultant for the Krebsliga Beider Basel and consultant Quality Assurance mammography screening for the breast screening program in Thurgau.
I am author or co-author of more than 20 peer-reviewed papers and book chapters in his area and peer reviewer for scientific journals. I am fluent in English, Dutch, German & French.
My main interest includes breast cancer screening, assessment, digital mammography and the implementation of quality assured services.